Article Text

Download PDFPDF
Incidence and severity of retinopathy of prematurity in Turkey
  1. Ahmet Yagmur Bas1,
  2. Esin Koc2,
  3. Ugur Dilmen3,
  4. ROP Neonatal Study Group
    1. 1Department of Neonatology, Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital, Ankara, Turkey
    2. 2Department of Neonatology, Gazi University Faculty of Medicine, Ankara, Turkey
    3. 3Department of Neonatology, Dr. Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey
    1. Correspondence to Dr Ahmet Yagmur Bas, Department of Neonatology, Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital, Etlik, Keciören, Ankara 06010, Turkey; yagmur32{at}yahoo.com

    Abstract

    Background The purpose of this study was to estimate the current incidence of retinopathy of prematurity (ROP) and the need for treatment in preterm infants in Turkey.

    Methods The study included preterm infants who had been screened for ROP between 2011 and 2013 in 49 neonatal intensive care units. Infants with birth weight (BW) ≤1500 g or ≤32 weeks’ gestational age and those with BW >1500 g or >32 weeks’ GA with an unstable clinical course were included. The incidence of any ROP or severe ROP and treatment modalities were determined.

    Results The study population included 15 745 preterm infants: 11 803 (75%) with GA ≤32 weeks, and 3942 (25%) with GA >32 weeks. Overall, 30% were found to have any stage of ROP, and 5% had severe ROP. Severe ROP was diagnosed in 8.2% of infants with BW ≤1500 g and 0.6% of infants with BW >1500 g. Of all infants diagnosed with ROP, 16.5% needed laser photocoagulation, and 20 patients born at >32 weeks’ GA required this treatment modality. Vitroretinal surgery was performed in 28 infants with severe ROP: 23 with GA ≤28 weeks and 5 with GA 29–32 weeks.

    Conclusions The findings of our study have the important implication that more mature babies are at risk of severe ROP requiring treatment. An effective programme for detecting and treating ROP should be established in Turkey.

    Trial registration number orcid.org/0000-0002-1329-2167.

    • Retina
    • Epidemiology
    • Neovascularisation
    • Child health (paediatrics)
    • Treatment Lasers

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.